Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

Adjuvant effects elicited by novel oligosaccharide variants of detoxified meningococcal lipopolysaccharides on Neisseria meningitidis recombinant PorA protein: a comparison in mice.

Mehta OH, Norheim G, Hoe JC, Rollier CS, Nagaputra JC, Makepeace K, Saleem M, Chan H, Ferguson DJ, Jones C, Sadarangani M, Hood DW, Feavers I, Derrick JP, Pollard AJ, Moxon ER.

PLoS One. 2014 Dec 29;9(12):e115713. doi: 10.1371/journal.pone.0115713. eCollection 2014.

2.

Neisseria meningitidis native outer membrane vesicles containing different lipopolysaccharide glycoforms as adjuvants for meningococcal and nonmeningococcal antigens.

Nagaputra JC, Rollier CS, Sadarangani M, Hoe JC, Mehta OH, Norheim G, Saleem M, Chan H, Derrick JP, Feavers I, Pollard AJ, Moxon ER.

Clin Vaccine Immunol. 2014 Feb;21(2):234-42. doi: 10.1128/CVI.00561-13. Epub 2013 Dec 18.

3.

Construction of Opa-positive and Opa-negative strains of Neisseria meningitidis to evaluate a novel meningococcal vaccine.

Sadarangani M, Hoe JC, Callaghan MJ, Jones C, Chan H, Makepeace K, Daniels-Treffandier H, Deadman ME, Bayliss C, Feavers I, van der Ley P, Pollard AJ.

PLoS One. 2012;7(12):e51045. doi: 10.1371/journal.pone.0051045. Epub 2012 Dec 12.

4.

Design and simulation of 25 Gb/s optical OFDM transceiver ASICs.

Milder PA, Bouziane R, Koutsoyannis R, Berger CR, Benlachtar Y, Killey RI, Glick M, Hoe JC.

Opt Express. 2011 Dec 12;19(26):B337-42. doi: 10.1364/OE.19.00B337.

PMID:
22274040
5.

Single nucleotide polymorphisms in the Toll-like receptor 3 and CD44 genes are associated with persistence of vaccine-induced immunity to the serogroup C meningococcal conjugate vaccine.

Moore CE, Hennig BJ, Perrett KP, Hoe JC, Lee SJ, Fletcher H, Brocklebank D, O'Connor D, Snape MD, Hall AJ, Segal S, Hill AV, Pollard AJ.

Clin Vaccine Immunol. 2012 Mar;19(3):295-303. doi: 10.1128/CVI.05379-11. Epub 2011 Dec 28.

6.

Design studies for ASIC implementations of 28 GS/s optical QPSK- and 16-QAM-OFDM transceivers.

Bouziane R, Milder P, Koutsoyannis R, Benlachtar Y, Hoe JC, Püschel M, Glick M, Killey RI.

Opt Express. 2011 Oct 10;19(21):20857-64. doi: 10.1364/OE.19.020857.

PMID:
21997095
7.

Haemophilus influenzae type b carriage and novel bacterial population structure among children in urban Kathmandu, Nepal.

Williams EJ, Lewis J, John T, Hoe JC, Yu L, Dongol S, Kelly DF, Griffiths DT, Shah A, Limbu B, Pradhan R, Mawas F, Shrestha S, Thorson S, Werno AM, Murdoch DR, Adhikari N, Pollard AJ.

J Clin Microbiol. 2011 Apr;49(4):1323-30. doi: 10.1128/JCM.02200-10. Epub 2011 Jan 26.

8.

Investigating the candidacy of LPS-based glycoconjugates to prevent invasive meningococcal disease: immunology of glycoconjugates with high carbohydrate loading.

Cox AD, St Michael F, Neelamegan D, Lacelle S, Cairns CM, Giuliani MM, Biolchi A, Hoe JC, Moxon ER, Richards JC.

Glycoconj J. 2010 Oct;27(7-9):643-8. doi: 10.1007/s10719-010-9309-y. Epub 2010 Oct 5.

PMID:
20922476
9.

Immune inhibitory ligand CD200 induction by TLRs and NLRs limits macrophage activation to protect the host from meningococcal septicemia.

Mukhopadhyay S, Plüddemann A, Hoe JC, Williams KJ, Varin A, Makepeace K, Aknin ML, Bowdish DM, Smale ST, Barclay AN, Gordon S.

Cell Host Microbe. 2010 Sep 16;8(3):236-47. doi: 10.1016/j.chom.2010.08.005.

10.

Generation of optical OFDM signals using 21.4 GS/s real time digital signal processing.

Benlachtar Y, Watts PM, Bouziane R, Milder P, Rangaraj D, Cartolano A, Koutsoyannis R, Hoe JC, Püschel M, Glick M, Killey RI.

Opt Express. 2009 Sep 28;17(20):17658-68. doi: 10.1364/OE.17.017658.

PMID:
19907551
11.

Phosphoethanolamine is located at the 6-position and not at the 7-position of the distal heptose residue in the lipopolysaccharide from Neisseria meningitidis.

St Michael F, Vinogradov E, Wenzel CQ, McIntosh B, Li J, Hoe JC, Richards JC, Cox AD.

Glycobiology. 2009 Dec;19(12):1436-45. doi: 10.1093/glycob/cwp117. Epub 2009 Aug 8.

PMID:
19666923
12.

Challenges and progress in the development of a serogroup B meningococcal vaccine.

Lewis S, Sadarangani M, Hoe JC, Pollard AJ.

Expert Rev Vaccines. 2009 Jun;8(6):729-45. doi: 10.1586/erv.09.30. Review.

PMID:
19485754
13.

The macrophage scavenger receptor A is host-protective in experimental meningococcal septicaemia.

Plüddemann A, Hoe JC, Makepeace K, Moxon ER, Gordon S.

PLoS Pathog. 2009 Feb;5(2):e1000297. doi: 10.1371/journal.ppat.1000297. Epub 2009 Feb 13.

14.

Naturally-occurring human serum antibodies to inner core lipopolysaccharide epitopes of Neisseria meningitidis protect against invasive meningococcal disease caused by isolates displaying homologous inner core structures.

Jäkel A, Plested JS, Hoe JC, Makepeace K, Gidney MA, Lacelle S, St Michael F, Cox AD, Richards JC, Moxon ER.

Vaccine. 2008 Dec 2;26(51):6655-63. doi: 10.1016/j.vaccine.2008.09.041.

PMID:
18835574
15.

Neisseria meningitidis escape from the bactericidal activity of a monoclonal antibody is mediated by phase variation of lgtG and enhanced by a mutator phenotype.

Bayliss CD, Hoe JC, Makepeace K, Martin P, Hood DW, Moxon ER.

Infect Immun. 2008 Nov;76(11):5038-48. doi: 10.1128/IAI.00395-08. Epub 2008 Aug 11.

Supplemental Content

Support Center